These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24919541)

  • 1. Localization of the androgen-synthesizing enzymes, androgen receptor, and sex steroids in the vagina: possible implications for the treatment of postmenopausal sexual dysfunction.
    Bertin J; Dury AY; Ouellet J; Pelletier G; Labrie F
    J Sex Med; 2014 Aug; 11(8):1949-61. PubMed ID: 24919541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the estrogen receptors and steroidogenic enzymes involved in estradiol formation in the monkey vagina.
    Bertin J; Ouellet J; Dury AY; Pelletier G; Labrie F
    Am J Obstet Gynecol; 2014 Nov; 211(5):499.e1-9. PubMed ID: 24928055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
    Menopause; 2009; 16(5):923-31. PubMed ID: 19424093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ovariectomy and dehydroepiandrosterone (DHEA) on vaginal wall thickness and innervation.
    Pelletier G; Ouellet J; Martel C; Labrie F
    J Sex Med; 2012 Oct; 9(10):2525-33. PubMed ID: 22905785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is vulvovaginal atrophy due to a lack of both estrogens and androgens?
    Labrie F; Martel C; Pelletier G
    Menopause; 2017 Apr; 24(4):452-461. PubMed ID: 27875388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight on the Intracrinology of Menopause: Androgen Production within the Human Vagina.
    Cellai I; Di Stasi V; Comeglio P; Maseroli E; Todisco T; Corno C; Filippi S; Cipriani S; Sorbi F; Fambrini M; Petraglia F; Scavello I; Rastrelli G; Acciai G; Villanelli F; Danza G; Sarchielli E; Guarnieri G; Morelli A; Maggi M; Vignozzi L
    Endocrinology; 2021 Feb; 162(2):. PubMed ID: 33247714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Bérubé R; Bélanger P; Berger L; Gilbert L; Martel C; Balser J
    Menopause; 2009; 16(5):897-906. PubMed ID: 19436226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen formation and metabolism in the pulmonary epithelial cell line A549: expression of 17beta-hydroxysteroid dehydrogenase type 5 and 3alpha-hydroxysteroid dehydrogenase type 3.
    Provost PR; Blomquist CH; Godin C; Huang XF; Flamand N; Luu-The V; Nadeau D; Tremblay Y
    Endocrinology; 2000 Aug; 141(8):2786-94. PubMed ID: 10919264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Science of intracrinology in postmenopausal women.
    Labrie F; Bélanger A; Pelletier G; Martel C; Archer DF; Utian WH
    Menopause; 2017 Jun; 24(6):702-712. PubMed ID: 28098598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of androgen receptors, aromatase, and 5-alpha reductase in the human vagina with menopausal status.
    Berman JR; Almeida FG; Jolin J; Raz S; Chaudhuri G; Gonzalez-Cadavid NF
    Fertil Steril; 2003 Apr; 79(4):925-31. PubMed ID: 12749432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy.
    Labrie F; Derogatis L; Archer DF; Koltun W; Vachon A; Young D; Frenette L; Portman D; Montesino M; Côté I; Parent J; Lavoie L; Beauregard A; Martel C; Vaillancourt M; Balser J; Moyneur É;
    J Sex Med; 2015 Dec; 12(12):2401-12. PubMed ID: 26597311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration.
    Ke Y; Labrie F; Gonthier R; Simard JN; Bergeron D; Martel C; Vaillancourt M; Montesino M; Lavoie L; Archer DF; Balser J; Moyneur E;
    J Steroid Biochem Mol Biol; 2015 Nov; 154():186-96. PubMed ID: 26291918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Gilbert L; Martel C; Balser J
    J Sex Med; 2014 Jul; 11(7):1766-85. PubMed ID: 24774442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of type 5 17beta-hydroxysteroid dehydrogenase, 3beta-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry.
    El-Alfy M; Luu-The V; Huang XF; Berger L; Labrie F; Pelletier G
    Endocrinology; 1999 Mar; 140(3):1481-91. PubMed ID: 10067877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women.
    Goldstein I; Alexander JL
    J Sex Med; 2005 Sep; 2 Suppl 3():154-65. PubMed ID: 16422792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
    Menopause; 2009; 16(5):907-22. PubMed ID: 19436225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DHEA and peripheral androgen and estrogen formation: intracinology.
    Labrie F; Bélanger A; Simard J; Van Luu-The ; Labrie C
    Ann N Y Acad Sci; 1995 Dec; 774():16-28. PubMed ID: 8597456
    [No Abstract]   [Full Text] [Related]  

  • 18. Dehydroepiandrosterone therapy as female androgen replacement.
    Saltzman E; Guay A
    Semin Reprod Med; 2006 Apr; 24(2):97-105. PubMed ID: 16633983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label study.
    Bouchard C; Labrie F; Derogatis L; Girard G; Ayotte N; Gallagher J; Cusan L; Archer DF; Portman D; Lavoie L; Beauregard A; Côté I; Martel C; Vaillancourt M; Balser J; Moyneur E;
    Horm Mol Biol Clin Investig; 2016 Mar; 25(3):181-90. PubMed ID: 26725467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intravaginal dehydroepiandrosterone on vaginal histomorphology, sex steroid receptor expression and cell proliferation in the rat.
    Berger L; El-Alfy M; Labrie F
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):67-80. PubMed ID: 18242978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.